Literature DB >> 9122238

The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.

M M Montano1, B S Katzenellenbogen.   

Abstract

Antiestrogens are thought to exert most of their beneficial effects in breast cancer by antagonizing the actions of estrogen. We report here that antiestrogens also stimulate the expression of quinone reductase (QR) [NAD(P)H:quinone oxidoreductase, EC 1.6.99.2], which may provide protective effects against the toxicity and mutagenicity caused by quinones. QR is up-regulated by low concentrations of antiestrogens (trans-hydroxytamoxifen, tamoxifen, and ICI182,780) in estrogen receptor (ER)-containing breast cancer cells, and this increase is suppressed by estrogen via an ER-dependent mechanism. Since regulation of the QR gene, as well as other genes involved in detoxification such as the glutathione S-transferase Ya subunit (GST Ya) gene, is known to be mediated by an electrophile/antioxidant response element (EpRE/ARE), we examined the effects of antiestrogens on a 41-bp electrophile responsive region derived from the GST Ya gene. Transfection of this EpRE-containing region into ER-negative breast cancer cells in the presence or absence of an expression vector for the human ER, as well as mutagenesis studies, revealed that the EpRE-containing construct was activated by antiestrogen to the same extent as by tert-butylhydroquinone (TBHQ), a known activator of EpREs; however, only the stimulation by antiestrogen, and not TBHQ, required ER and was repressed by estradiol, although activation by both inducers mapped to the same 10-bp EpRE consensus sequence. Thus, there appear to be two pathways for QR induction, one that is activated by electrophile inducers such as TBHQ and is ER independent, and a second that is antiestrogen regulated and ER dependent; both pathways act through the EpRE. The anticancer action of antiestrogens may thus derive not only from the already well-known repression of estrogen-stimulated activities but also from the activation of detoxifying enzymes, such as QR, that may contribute to the beneficial antioxidant activity of antiestrogens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122238      PMCID: PMC20131          DOI: 10.1073/pnas.94.6.2581

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.

Authors:  M E Herman; B S Katzenellenbogen
Journal:  J Steroid Biochem Mol Biol       Date:  1996-10       Impact factor: 4.292

Review 2.  Use of pure antioestrogens to elucidate the mode of action of oestrogens.

Authors:  A E Wakeling
Journal:  Biochem Pharmacol       Date:  1995-05-26       Impact factor: 5.858

Review 3.  Antioxidant response element.

Authors:  A K Jaiswal
Journal:  Biochem Pharmacol       Date:  1994-08-03       Impact factor: 5.858

4.  Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene.

Authors:  N N Yang; M Venugopalan; S Hardikar; A Glasebrook
Journal:  Science       Date:  1996-08-30       Impact factor: 47.728

5.  The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.

Authors:  M M Montano; V Müller; A Trobaugh; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1995-07

6.  Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat.

Authors:  M Ahotupa; P Hirsimäki; R Pärssinen; E Mäntylä
Journal:  Carcinogenesis       Date:  1994-05       Impact factor: 4.944

7.  Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.

Authors:  C K Wrenn; B S Katzenellenbogen
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

8.  Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression.

Authors:  K Yoshioka; T Deng; M Cavigelli; M Karin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.

Authors:  P Webb; G N Lopez; R M Uht; P J Kushner
Journal:  Mol Endocrinol       Date:  1995-04

10.  Electrophile and antioxidant regulation of enzymes that detoxify carcinogens.

Authors:  T Prestera; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more
  25 in total

Review 1.  Estrogen receptor and the SERM concept.

Authors:  G G Kuiper; G J van den Bemd; J P van Leeuwen
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Phytoestrogen therapy for menopausal symptoms?

Authors:  S R Davis
Journal:  BMJ       Date:  2001-08-18

3.  Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.

Authors:  P G Martini; R Delage-Mourroux; D M Kraichely; B S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage.

Authors:  Nicole R Bianco; Laura J Chaplin; Monica M Montano
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

5.  Estrogen induces distinct patterns of microRNA expression within the mouse uterus.

Authors:  Warren B Nothnick; Caitlin Healy
Journal:  Reprod Sci       Date:  2010-08-18       Impact factor: 3.060

6.  Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells.

Authors:  Nirmala Krishnamurthy; Lili Liu; Xiahui Xiong; Junran Zhang; Monica M Montano
Journal:  Cancer Biol Ther       Date:  2015-04-07       Impact factor: 4.742

Review 7.  Minireview: Estrogen receptor-beta: mechanistic insights from recent studies.

Authors:  Bonnie J Deroo; Adrian V Buensuceso
Journal:  Mol Endocrinol       Date:  2010-04-02

8.  Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse.

Authors:  Monica M Montano; Candida L Desjardins; Yong Qui Doughman; Yee-Hsee Hsieh; Yanduan Hu; Heather M Bensinger; Connie Wang; Julian E Stelzer; Thomas E Dick; Brian D Hoit; Margaret P Chandler; Xin Yu; Michiko Watanabe
Journal:  Cardiovasc Res       Date:  2013-04-11       Impact factor: 10.787

9.  Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

Authors:  Carolyn D DuSell; Erik R Nelson; Bryan M Wittmann; Jackie A Fretz; Dmitri Kazmin; Russell S Thomas; J Wesley Pike; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-09

10.  The regulation of MS-KIF18A expression and cross talk with estrogen receptor.

Authors:  Margalit Zusev; Dafna Benayahu
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.